Edition:
United States

MiMedx Group Inc (MDXG.OQ)

MDXG.OQ on NASDAQ Stock Exchange Capital Market

14.84USD
21 Jul 2017
Change (% chg)

$-0.15 (-1.00%)
Prev Close
$14.99
Open
$15.00
Day's High
$15.26
Day's Low
$14.84
Volume
208,882
Avg. Vol
338,829
52-wk High
$16.20
52-wk Low
$6.94

Latest Key Developments (Source: Significant Developments)

MiMedx reports Q2 revenue of $76.4 mln
Thursday, 13 Jul 2017 04:20pm EDT 

July 13 (Reuters) - Mimedx Group Inc :MiMedx announces that its second quarter revenue exceeds the guidance range.Q2 revenue $76.4 million versus I/B/E/S view $74.2 million.MiMedx Group Inc says Q2 2017 revenue of $76.4 million exceeds MiMedx guidance range of $73.5 to $75.0 million.  Full Article

MiMedx says contract with AvKARE expired
Wednesday, 5 Jul 2017 11:46am EDT 

July 5 (Reuters) - MiMedx Group Inc ::MiMedx agreement with AvKARE expires as planned following completion of contract wind-down.MiMedx and AvKARE began planning wind-down of contract in 2015, leading up to final expiration of contract on June 30, 2017.Says expect final process related to inventory buy back will be completed within next 90 days, in accordance with contract.  Full Article

Mimedx Epifix receives coverage from Kaiser Permanente
Thursday, 4 May 2017 08:30am EDT 

May 4 (Reuters) - Mimedx Group Inc : :Mimedx Epifix receives coverage from Kaiser Permanente.Company's Epifix product has received coverage from insurer kaiser permanente, effective April 1, 2017.  Full Article

MiMedx Q1 earnings per share $0.04
Friday, 28 Apr 2017 07:00am EDT 

April 28 (Reuters) - Mimedx Group Inc :Mimedx announces record results for first quarter of 2017.Sees fy 2017 adjusted earnings per share $0.31 to $0.33.Sees fy 2017 gaap earnings per share $0.18 to $0.20.Q1 earnings per share $0.04.Sees q2 2017 revenue $73.5 million to $75 million.Sees fy 2017 revenue $303.5 million to $307 million.Q1 revenue rose 36 percent to $72.6 million.Q1 earnings per share view $0.07, revenue view $71.9 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $0.31, revenue view $303.5 million -- Thomson Reuters I/B/E/S.Q2 revenue view $71.7 million -- Thomson Reuters I/B/E/S.Qtrly adjusted diluted net income per share $ 0.07.  Full Article

MiMedx Group Q1 revenue $72.6 million
Thursday, 13 Apr 2017 08:30am EDT 

Mimedx Group Inc : Q1 revenue $72.6 million versus i/b/e/s view $70.2 million . Mimedx group inc - qtrly revenue of $72.6 million exceeds upper end of mimedx guidance range .Q1 revenue view $70.2 million -- Thomson Reuters I/B/E/S.  Full Article

Mimedx audit committee announces completion of investigation
Wednesday, 1 Mar 2017 07:17pm EST 

Mimedx Group Inc : Mimedx audit committee announces completion of its investigation . Audit committee finds no wrongdoing by Mimedx management . Audit committee's investigation determined that company has appropriately recognized revenue .Mimedx- audit committee investigation found no credible evidence to indicate that any changes to co's previously issued financial statements are necessary.  Full Article

Mimedx audit committee announces completion of investigation
Wednesday, 1 Mar 2017 06:44pm EST 

Mimedx Group Inc : Mimedx audit committee announces completion of its investigation . Audit committee finds no wrongdoing by Mimedx management . Audit committee's investigation determined that company has appropriately recognized revenue .Mimedx- audit committee investigation found no credible evidence to indicate that any changes to co's previously issued financial statements are necessary.  Full Article

Mimedx reports Q4 earnings per share $0.05
Thursday, 23 Feb 2017 08:00am EST 

Mimedx Group Inc : Mimedx announces 2016 record results . Sees FY 2017 GAAP earnings per share $0.18 to $0.20 . Q4 earnings per share $0.05 . Q4 revenue $69.9 million versus I/B/E/S view $71.1 million . Q4 earnings per share view $0.08 -- Thomson Reuters I/B/E/S . Sees FY 2017 revenue $302 million to $307 million . Sees Q1 2017 revenue $69.5 million to $72.5 million . Sees Q1 2017 revenue up 30 to 36 percent . Mimedx group inc sees adjusted EPS for 2017 to be in range of $0.31 to $0.33 . Says 2017 adjusted EBITDA expected to be in range of 21% to 23% of revenue . Q1 revenue view $69.8 million -- Thomson Reuters I/B/E/S . FY2017 earnings per share view $0.29, revenue view $302.6 million -- Thomson Reuters I/B/E/S .Mimedx Group Inc - co authorized an additional increase of $10 million to share repurchase program, bringing total authorized to date to $86 million.  Full Article

MiMedx board authorizes $10 mln increase to company's share repurchase program
Monday, 6 Feb 2017 06:00am EST 

MiMedx Group Inc - : MiMedx board of directors authorizes $10 million increase to the company's share repurchase program . MiMedx board of directors authorizes $10 million increase to the company's share repurchase program .MiMedx Group Inc says board of directors authorizes an increase of $10 million to company's share repurchase program.  Full Article

Mimedx group sees FY 2017 adjusted earnings per share $0.31-$0.33
Monday, 9 Jan 2017 04:59pm EST 

Mimedx Group Inc : Sees fy 2017 adjusted earnings per share $0.31 to $0.33 . Sees fy 2017 gaap earnings per share $0.18 to $0.20 . Q4 revenue $71.6 million versus i/b/e/s view $70.7 million . Sees fy 2017 revenue $302 million to $307 million . Sees q1 2017 revenue $69.5 million to $72.5 million . Sees fy 2016 revenue up 32 percent . Sees q1 2017 revenue up 29 to 35 percent . Mimedx group inc says gross profit margins for 2017 expected to be in range of 86% to 88% .Mimedx Group Inc - mimedx reiterated its full year 2017 guidance.  Full Article

BRIEF-MiMedx Group announces data showing colorectal anastomotic leak rate reduction

* Announced presentation of clinical data showing that use of AmnioFix around colorectal anastomoses can reduce post-operative leak rates